WuXi AppTec (OTCMKTS:WUXAY) Sets New 52-Week High – Should You Buy?

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAYGet Free Report) reached a new 52-week high during trading on Wednesday . The company traded as high as $19.72 and last traded at $19.72, with a volume of 1218 shares traded. The stock had previously closed at $19.60.

Analysts Set New Price Targets

Separately, Zacks Research raised shares of WuXi AppTec to a “hold” rating in a research note on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, WuXi AppTec presently has an average rating of “Moderate Buy”.

Check Out Our Latest Stock Report on WuXi AppTec

WuXi AppTec Price Performance

The stock has a 50 day moving average of $16.81 and a two-hundred day moving average of $15.32.

WuXi AppTec (OTCMKTS:WUXAYGet Free Report) last posted its quarterly earnings data on Monday, April 27th. The company reported $0.23 EPS for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The firm had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.59 billion.

WuXi AppTec Company Profile

(Get Free Report)

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.

Recommended Stories

Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.